Purinergic Signaling in Mast Cell Degranulation and Asthma
暂无分享,去创建一个
[1] K. Jacobson,et al. A3 Adenosine Receptors as Modulators of Inflammation: From Medicinal Chemistry to Therapy , 2018, Medicinal research reviews.
[2] Koichi Ito,et al. UDP/P2Y6 receptor signaling regulates IgE-dependent degranulation in human basophils. , 2017, Allergology international : official journal of the Japanese Society of Allergology.
[3] P. Barnes,et al. Contrasting effects of ATP and adenosine on capsaicin challenge in asthmatic patients. , 2017, Pulmonary pharmacology & therapeutics.
[4] S. Menon,et al. Design and synthesis of novel xanthine derivatives as potent and selective A2B adenosine receptor antagonists for the treatment of chronic inflammatory airway diseases. , 2017, European journal of medicinal chemistry.
[5] E. Akiva,et al. Mast cells are directly activated by contact with cancer cells by a mechanism involving autocrine formation of adenosine and autocrine/paracrine signaling of the adenosine A3 receptor. , 2017, Cancer letters.
[6] T. Schöneberg,et al. Prostaglandin E2 glyceryl ester is an endogenous agonist of the nucleotide receptor P2Y6 , 2017, Scientific Reports.
[7] D. Hinds,et al. Gene‐based analysis of regulatory variants identifies 4 putative novel asthma risk genes related to nucleotide synthesis and signaling , 2017, The Journal of allergy and clinical immunology.
[8] H. Yatsuya,et al. Increased airway hyperresponsiveness to adenosine in patients with aspirin intolerant asthma. , 2017, Allergology international : official journal of the Japanese Society of Allergology.
[9] I. Matsuoka,et al. Divergent regulatory roles of extracellular ATP in the degranulation response of mouse bone marrow‐derived mast cells , 2017, International immunopharmacology.
[10] E. Gendaszewska-Darmach,et al. Nucleoside 5′-O-monophosphorothioates as modulators of the P2Y14 receptor and mast cell degranulation , 2016, Oncotarget.
[11] P. Barnes,et al. Extracellular Adenosine 5'-Triphosphate in Obstructive Airway Diseases. , 2016, Chest.
[12] Mika Watanabe,et al. Extracellular ATP is involved in dsRNA-induced MUC5AC production via P2Y2R in human airway epithelium , 2016, Respiratory Research.
[13] J. Linden,et al. Purinergic regulation of the immune system , 2016, Nature Reviews Immunology.
[14] K. Wareham,et al. P2X7 receptors induce degranulation in human mast cells , 2016, Purinergic Signalling.
[15] K. Jacobson,et al. Peripheral Adenosine A3 Receptor Activation Causes Regulated Hypothermia in Mice That Is Dependent on Central Histamine H1 Receptors , 2016, The Journal of Pharmacology and Experimental Therapeutics.
[16] F. Cao,et al. Effect of P2X4R on airway inflammation and airway remodeling in allergic airway challenge in mice , 2015, Molecular medicine reports.
[17] I. Matsuoka,et al. P2X7 receptor antagonist activity of the anti-allergic agent oxatomide. , 2015, European journal of pharmacology.
[18] F. Virgilio,et al. Purinergic signaling in the immune system , 2015, Autonomic Neuroscience.
[19] Dave Singh,et al. The novel inhaled glucocorticoid receptor agonist GW870086X protects against adenosine-induced bronchoconstriction in asthma. , 2015, The Journal of allergy and clinical immunology.
[20] P. Barnes,et al. Effects of Aerosolized Adenosine 5'-Triphosphate in Smokers and Patients With COPD. , 2015, Chest.
[21] R. Stevens,et al. Nucleotides Acting at P2Y Receptors: Connecting Structure and Function , 2015, Molecular Pharmacology.
[22] T. Himi,et al. Leukotriene E4 induces MUC5AC release from human airway epithelial NCI-H292 cells. , 2015, Allergology international : official journal of the Japanese Society of Allergology.
[23] F. Di Marco,et al. Effect of prasugrel in patients with asthma: results of PRINA, a randomized, double‐blind, placebo‐controlled, cross‐over study , 2015, Journal of thrombosis and haemostasis : JTH.
[24] G. Burnstock,et al. Purinergic signalling and immune cells , 2014, Purinergic Signalling.
[25] K. Jacobson,et al. The role of activated adenosine receptors in degranulation of human LAD2 mast cells , 2014, Purinergic Signalling.
[26] R. Doukky,et al. Regadenoson use in patients with chronic obstructive pulmonary disease: the state of current knowledge , 2014, International journal of chronic obstructive pulmonary disease.
[27] J. Sévigny,et al. Histamine Induces ATP Release from Human Subcutaneous Fibroblasts, via Pannexin-1 Hemichannels, Leading to Ca2+ Mobilization and Cell Proliferation* , 2013, The Journal of Biological Chemistry.
[28] Seiko F. Okada,et al. Mechanosensitive ATP Release Maintains Proper Mucus Hydration of Airways , 2013, Science Signaling.
[29] B. Fredholm,et al. Adenosine receptors as drug targets — what are the challenges? , 2013, Nature Reviews Drug Discovery.
[30] M. Checa,et al. Histamine, carbachol, and serotonin induce hyperresponsiveness to ATP in guinea pig tracheas: involvement of COX-2 pathway , 2013, Pflügers Archiv - European Journal of Physiology.
[31] K. Jacobson,et al. The role of P2Y14 and other P2Y receptors in degranulation of human LAD2 mast cells , 2013, Purinergic Signalling.
[32] X. Hua,et al. Gs-Coupled Adenosine Receptors Differentially Limit Antigen-Induced Mast Cell Activation , 2013, The Journal of Pharmacology and Experimental Therapeutics.
[33] X. Hua,et al. Adenosine increases nasal mucociliary clearance rate in mice through A2A and A2B adenosine receptors , 2013, The Laryngoscope.
[34] A. Galzin,et al. Evaluation of SSR161421, a novel orally active adenosine A3 receptor antagonist on pharmacology models. , 2013, European journal of pharmacology.
[35] G. Grassia,et al. Hyperresponsiveness to adenosine in sensitized Wistar rats over-expressing A1 receptor. , 2012, European journal of pharmacology.
[36] A. Ford,et al. A role for ATP in bronchoconstriction‐induced activation of guinea pig vagal intrapulmonary C‐fibres , 2012, The Journal of physiology.
[37] Wei Zhao,et al. Intracellular Adenosine Inhibits IgE-Dependent Degranulation of Human Skin Mast Cells , 2012, Journal of Clinical Immunology.
[38] K. Ley,et al. Regulation of Neutrophil Function by Adenosine , 2012, Arteriosclerosis, thrombosis, and vascular biology.
[39] X. Hua,et al. IL-4 Amplifies the Pro-Inflammatory Effect of Adenosine in Human Mast Cells by Changing Expression Levels of Adenosine Receptors , 2011, PloS one.
[40] H. Wise,et al. Reciprocal modulation of anti‐IgE induced histamine release from human mast cells by A1 and A2B adenosine receptors , 2011, British journal of pharmacology.
[41] Xi-Long Zheng,et al. Uridine adenosine tetraphosphate induces contraction of airway smooth muscle. , 2011, American journal of physiology. Lung cellular and molecular physiology.
[42] P. Barnes. Biochemical Basis of Asthma Therapy* , 2011, The Journal of Biological Chemistry.
[43] A. Mukherjee,et al. Allergic Asthma: Influence of Genetic and Environmental Factors* , 2011, The Journal of Biological Chemistry.
[44] W. Ko,et al. Differential Inhibitory Effects of CysLT1 Receptor Antagonists on P2Y6 Receptor-Mediated Signaling and Ion Transport in Human Bronchial Epithelia , 2011, PloS one.
[45] Wei Zhao,et al. Disparity in FcεRI-Induced Degranulation of Primary Human Lung and Skin Mast Cells Exposed to Adenosine , 2011, Journal of Clinical Immunology.
[46] M. Checa,et al. In airways ATP refills sarcoplasmic reticulum via P2X smooth muscle receptors and induces contraction through P2Y epithelial receptors , 2011, Pflügers Archiv - European Journal of Physiology.
[47] K. Jacobson,et al. P2Y(13) receptor is responsible for ADP-mediated degranulation in RBL-2H3 rat mast cells. , 2010, Pharmacological research.
[48] M. Idzko,et al. Lack of the purinergic receptor P2X7 results in resistance to contact hypersensitivity , 2010, The Journal of experimental medicine.
[49] T. Zuberbier,et al. Mast cell lines HMC‐1 and LAD2 in comparison with mature human skin mast cells – drastically reduced levels of tryptase and chymase in mast cell lines , 2010, Experimental dermatology.
[50] A. Nadeem,et al. Involvement of A1 adenosine receptors in altered vascular responses and inflammation in an allergic mouse model of asthma. , 2010, American journal of physiology. Heart and circulatory physiology.
[51] D. Mitchell,et al. Attenuation of chronic pulmonary inflammation in A2B adenosine receptor knockout mice. , 2010, American journal of respiratory cell and molecular biology.
[52] T. Kawakami,et al. FcεRI β‐chain ITAM amplifies PI3K‐signaling to ensure synergistic degranulation response via FcεRI and adenosine receptors , 2010, European journal of immunology.
[53] K. Jacobson,et al. UDP‐glucose acting at P2Y14 receptors is a mediator of mast cell degranulation , 2010, Biochemical pharmacology.
[54] S. Bulfone-Paus,et al. P2 receptor-mediated signaling in mast cell biology , 2010, Purinergic Signalling.
[55] M. Trevethick,et al. Design and application of locally delivered agonists of the adenosine A2A receptor , 2010, Expert review of clinical pharmacology.
[56] E. R. Mcfadden,et al. Safety of Binodenoson, a Selective Adenosine A2A Receptor Agonist Vasodilator Pharmacological Stress Agent, in Healthy Subjects With Mild Intermittent Asthma , 2009, Circulation. Cardiovascular imaging.
[57] K. Wareham,et al. Functional evidence for the expression of P2X1, P2X4 and P2X7 receptors in human lung mast cells , 2009, British journal of pharmacology.
[58] Bulanova Elena,et al. ATP induces P2X7 receptor‐independent cytokine and chemokine expression through P2X1 and P2X3 receptors in murine mast cells , 2009 .
[59] G. Tamura,et al. Regulation of adenosine 5′-triphosphate (ATP)-gated P2X4 receptors on tracheal smooth muscle cells , 2009, Respiratory Physiology & Neurobiology.
[60] J. Linden,et al. Adenosine A2A receptor activation reduces infarct size in the isolated, perfused mouse heart by inhibiting resident cardiac mast cell degranulation. , 2008, American journal of physiology. Heart and circulatory physiology.
[61] R. Tarran,et al. A2B adenosine receptors regulate the mucus clearance component of the lung's innate defense system. , 2008, American journal of respiratory cell and molecular biology.
[62] I. Biaggioni,et al. Effect of A2B Adenosine Receptor Gene Ablation on Proinflammatory Adenosine Signaling in Mast Cells1 , 2008, The Journal of Immunology.
[63] N. Nakatsuji,et al. Direct Development of Functionally Mature Tryptase/Chymase Double‐Positive Connective Tissue‐Type Mast Cells from Primate Embryonic Stem Cells , 2008, Stem cells.
[64] I. Biaggioni,et al. Effect of A2B Adenosine Receptor Gene Ablation on Adenosine-Dependent Regulation of Proinflammatory Cytokines , 2008, Journal of Pharmacology and Experimental Therapeutics.
[65] M. Breschi,et al. In vivo adenosine A(2B) receptor desensitization in guinea-pig airway smooth muscle: implications for asthma. , 2007, European journal of pharmacology.
[66] X. Hua,et al. Involvement of A1 adenosine receptors and neural pathways in adenosine-induced bronchoconstriction in mice. , 2007, American journal of physiology. Lung cellular and molecular physiology.
[67] Tiejuan Mi,et al. Genetic removal of the A2A adenosine receptor enhances pulmonary inflammation, mucin production, and angiogenesis in adenosine deaminase-deficient mice. , 2007, American journal of physiology. Lung cellular and molecular physiology.
[68] K. Kamiya,et al. Roles of P2X receptors and Ca2+ sensitization in extracellular adenosine triphosphate‐induced hyperresponsiveness in airway smooth muscle , 2007, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[69] M. Blackburn,et al. A3 adenosine receptor signaling contributes to airway mucin secretion after allergen challenge. , 2006, American journal of respiratory cell and molecular biology.
[70] K. Jacobson,et al. Adenosine receptors as therapeutic targets , 2006, Nature Reviews Drug Discovery.
[71] K. Jacobson,et al. CysLT1 leukotriene receptor antagonists inhibit the effects of nucleotides acting at P2Y receptors. , 2005, Biochemical pharmacology.
[72] M. Inoue,et al. Human adenosine A3 receptor leads to intracellular Ca2+ mobilization but is insufficient to activate the signaling pathway via phosphoinositide 3-kinase γ in mice , 2005 .
[73] P. Barnes,et al. Effects of aerosolized adenosine 5'-triphosphate vs adenosine 5'-monophosphate on dyspnea and airway caliber in healthy nonsmokers and patients with asthma. , 2005, Chest.
[74] K. Jacobson,et al. Activation of Th1 and Tc1 cell adenosine A2A receptors directly inhibits IL-2 secretion in vitro and IL-2-driven expansion in vivo. , 2005, Blood.
[75] D. Zeng,et al. The discovery of a selective, high affinity A(2B) adenosine receptor antagonist for the potential treatment of asthma. , 2005, Bioorganic & medicinal chemistry letters.
[76] M. Gallup,et al. Adenosine up‐regulation of the mucin gene, MU2, in asthma , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[77] James J. Lee,et al. A3 Adenosine Receptor Signaling Contributes to Airway Inflammation and Mucus Production in Adenosine Deaminase-Deficient Mice1 , 2004, The Journal of Immunology.
[78] D. Adriaensen,et al. Purinergic signalling in the lung: important in asthma and COPD? , 2004, Current opinion in pharmacology.
[79] D. Metcalfe,et al. Characterization of novel stem cell factor responsive human mast cell lines LAD 1 and 2 established from a patient with mast cell sarcoma/leukemia; activation following aggregation of FcepsilonRI or FcgammaRI. , 2003, Leukemia research.
[80] G. Nilsson,et al. Activation of mast cells by immunoglobulin E‐receptor cross‐linkage, but not through adenosine receptors, induces A1 expression and promotes survival , 2003, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[81] M. Jacobson,et al. References Subscriptions Permissions Email Alerts A Class I MHC-Restricted Recall Response to a Viral Peptide Is Highly Polyclonal Despite Stringent CDR3 Selection: Implications for Establishing Memory T Cell Repertoires in ''Real-World' ' Conditions , 2013 .
[82] M. Tsai,et al. Identification of A3 Receptor- and Mast Cell-Dependent and -Independent Components of Adenosine-Mediated Airway Responsiveness in Mice1 , 2003, The Journal of Immunology.
[83] J. Fozard. The case for a role for adenosine in asthma: almost convincing? , 2003, Current opinion in pharmacology.
[84] K. Broadley,et al. Mediators of adenosine- and ovalbumen-induced bronchoconstriction of sensitized guinea-pig isolated airways. , 2002, European journal of pharmacology.
[85] J. Fozard,et al. Suppression of Adenosine A3 Receptor-Mediated Hypotension and Mast Cell Degranulation in the Rat by Dexamethasone , 2002, Journal of Pharmacology and Experimental Therapeutics.
[86] D. Kellerman. P2Y(2) receptor agonists: a new class of medication targeted at improved mucociliary clearance. , 2002, Chest.
[87] Chang Jong Kim,et al. ATP-induced histamine release is in part related to Phospholipase A2- mediated arachidonic acid metabolism in rat peritoneal mast cells , 2001, Archives of pharmacal research.
[88] Beverly H. Koller,et al. Disruption of the A3 Adenosine Receptor Gene in Mice and Its Effect on Stimulated Inflammatory Cells* , 2000, The Journal of Biological Chemistry.
[89] M. Jacobson,et al. Adenosine and inosine increase cutaneous vasopermeability by activating A(3) receptors on mast cells. , 2000, The Journal of clinical investigation.
[90] M. K. James,et al. Aerosolization of P2Y(2)-receptor agonists enhances mucociliary clearance in sheep. , 1999, Journal of applied physiology.
[91] A. Korngreen,et al. Extracellular sodium regulates airway ciliary motility by inhibiting a P2X receptor , 1999, Nature.
[92] J. Butterfield,et al. ATP modulates anti-IgE-induced release of histamine from human lung mast cells. , 1999, American journal of respiratory cell and molecular biology.
[93] B. Fredholm,et al. Caffeine--an atypical drug of dependence. , 1998, Drug and alcohol dependence.
[94] Hidefumi Suzuki,et al. Inhibitory Effect of Adenosine on Degranulation of Human Cultured Mast Cells upon Cross-linking of FcϵRI , 1998 .
[95] R. K. Shepherd,et al. Inosine binds to A3 adenosine receptors and stimulates mast cell degranulation. , 1997, The Journal of clinical investigation.
[96] J. Linden,et al. Canine mast cell adenosine receptors: cloning and expression of the A3 receptor and evidence that degranulation is mediated by the A2B receptor. , 1997, Molecular pharmacology.
[97] J. J. Reeves,et al. Adenosine A3 receptors promote degranulation of rat mast cells both in vitro and in vivo , 1997, Inflammation Research.
[98] J. Nyce,et al. DNA antisense therapy for asthma in an animal model , 1997, Nature.
[99] R. K. Shepherd,et al. Adenosine-induced vasoconstriction in vivo. Role of the mast cell and A3 adenosine receptor. , 1996, Circulation research.
[100] P. von Wichert,et al. Effects of selective and non-selective phosphodiesterase inhibitors on tracheal mucus secretion in the rat. , 1996, European journal of pharmacology.
[101] J. Fozard,et al. Mast cell degranulation following adenosine A3 receptor activation in rats. , 1996, European journal of pharmacology.
[102] I. Biaggioni,et al. Adenosine A2b receptors evoke interleukin-8 secretion in human mast cells. An enprofylline-sensitive mechanism with implications for asthma. , 1995, The Journal of clinical investigation.
[103] T. Gettys,et al. Dexamethasone up-regulates A3 adenosine receptors in rat basophilic leukemia (RBL-2H3) cells. , 1995, Journal of immunology.
[104] D. Marquardt,et al. Cloning of two adenosine receptor subtypes from mouse bone marrow-derived mast cells. , 1994, Journal of immunology.
[105] A. Yen,et al. IgE and adenosine 5' triphosphate receptors on immature murine mast cells are functionally linked to signal transduction mechanisms. , 1992, The Journal of allergy and clinical immunology.
[106] G. Stiles,et al. Molecular cloning and characterization of an adenosine receptor: the A3 adenosine receptor. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[107] Z. Jaffar,et al. Histamine secretion from mast cells stimulated with ATP , 1990, Agents and Actions.
[108] J. Cunha-Melo,et al. Activation of phospholipase C via adenosine receptors provides synergistic signals for secretion in antigen-stimulated RBL-2H3 cells. Evidence for a novel adenosine receptor. , 1990, The Journal of biological chemistry.
[109] J. Cunha-Melo,et al. Treatment with dexamethasone down-regulates IgE-receptor-mediated signals and up-regulates adenosine-receptor-mediated signals in a rat mast cell (RBL-2H3) line. , 1990, Journal of immunology.
[110] I. Ziment. Theophylline and mucociliary clearance. , 1987, Chest.
[111] M. Lohse,et al. Dual actions of adenosine on rat peritoneal mast cells , 1987, Naunyn-Schmiedeberg's Archives of Pharmacology.
[112] A. Wanner. Effects of methylxanthines on airway mucociliary function. , 1985, The American journal of medicine.
[113] S. Holgate,et al. Adenosine inhibits and potentiates IgE-dependent histamine release from human lung mast cells by an A2-purinoceptor mediated mechanism. , 1984, Biochemical pharmacology.
[114] S. Holgate,et al. Adenosine-induced bronchoconstriction in asthma. Antagonism by inhaled theophylline. , 1984, The American review of respiratory disease.
[115] S. Holgate,et al. Adenosine inhibits and potentiates IgE‐dependent histamine release from human basophils by an A2‐receptor mediated mechanism , 1983, British journal of pharmacology.
[116] G. Schultze-Werninghaus,et al. The clinical and pharmacological history of theophylline: first report on the bronchospasmolytic action in man by S. R. Hirsch in Frankfurt (Main) 1922 , 1982, Clinical allergy.
[117] R. Rothstein. Intravenous theophylline therapy in asthma: a clinical update. , 1980, Annals of emergency medicine.
[118] T. Sullivan,et al. Potentiation of mast cell mediator release by adenosine. , 1978, Journal of immunology.
[119] R. Whelan. The role of histamine. , 1960, American heart journal.
[120] M. Sitkovsky,et al. Adenosine and adenosine receptors in the pathogenesis and treatment of rheumatic diseases , 2017, Nature Reviews Rheumatology.
[121] C. Billington,et al. β2 Agonists. , 2017, Handbook of experimental pharmacology.
[122] Qun Zhou,et al. [Effect of aminophylline and simvastatin on airway inflammation and mucus hypersecretion in rats with chronic obstructive pulmonary disease]. , 2016, Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences.
[123] R. Stevens,et al. Nucleotides Acting at P 2 Y Receptors : Connecting Structure and Function , 2015 .
[124] Xiaowei Jin,et al. Inosine Binds to A 3 Adenosine Receptors and Stimulates Mast Cell Degranulation , 2013 .
[125] L. Donnelly,et al. Therapy for Chronic Obstructive Pulmonary Disease in the 21st Century , 2012, Drugs.
[126] K. Jacobson,et al. Xanthines as adenosine receptor antagonists. , 2011, Handbook of experimental pharmacology.
[127] J. Fozard. From Hypertension (+) to Asthma: Interactions with the Adenosine A 3 Receptor from a Personal Perspective , 2010 .
[128] A. Nadeem,et al. Involvement of A 1 adenosine receptors in altered vascular responses and inflammation in an allergic mouse model of asthma , 2010 .
[129] K. Wareham,et al. Functional evidence for the expression of P2X1, P2X4 and P2X7 receptors in human lung mast cells , 2009, British journal of pharmacology.
[130] F. Koch-Nolte,et al. ATP induces P2X7 receptor-independent cytokine and chemokine expression through P2X1 and P2X3 receptors in murine mast cells. , 2009, Journal of Leukocyte Biology.
[131] J. Linden,et al. Adenosine A2A receptor activation reduces infarct size in the isolated, perfused mouse heart by inhibiting resident cardiac mast cell degranulation. , 2008, American journal of physiology. Heart and circulatory physiology.
[132] M. Inoue,et al. Human adenosine A(3) receptor leads to intracellular Ca(2+) mobilization but is insufficient to activate the signaling pathway via phosphoinositide 3-kinase gamma in mice. , 2005, Biochemical Pharmacology.
[133] G. Burnstock,et al. Immunolocalisation of P2X and P2Y nucleotide receptors in the rat nasal mucosa , 2004, Cell and Tissue Research.
[134] M. King,et al. Effect of aerosolized uridine-5'-triphosphate on airway clearance with cough in patients with primary ciliary dyskinesia. , 1999, American journal of respiratory and critical care medicine.
[135] T. Nakahata,et al. Inhibitory effect of adenosine on degranulation of human cultured mast cells upon cross-linking of Fc epsilon RI. , 1998, Biochemical and biophysical research communications.
[136] R. Pauwels,et al. Characterization of the adenosine receptors in the airways. , 1995, Archives internationales de pharmacodynamie et de therapie.
[137] G. Dewald,et al. Establishment of an immature mast cell line from a patient with mast cell leukemia. , 1988, Leukemia research.
[138] S. Holgate,et al. The role of histamine in allergen and adenosine-induced bronchoconstriction. , 1987, International archives of allergy and applied immunology.
[139] The Inhibitory Effect , 2022 .